logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Kylee Maclachlan

Memorial Sloan Kettering Cancer Center
H指数:19
被引数:1,744

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dynamic risk stratification in smoldering multiple myeloma: Integrating evolving biomarkers with the 2/20/20 Model

动态风险分层在冒烟性多发性骨髓瘤中的应用：整合演变中的生物标志物与2/20/20模型

HemaSphere
IF14.6
2026-09-240
OAAI
Theresia Akhlaghi; David Nemirovsky; Kylee H. Maclachlan; Ross S. Firestone; Neha Korde; Sham Mailankody; Alexander M. Lesokhin; Hani Hassoun; Dhwani Patel; Urvi A. Shah; Carlyn R. Tan; Heather J. Landau; Gunjan L. Shah; Michael Scordo; Anish K. Simhal; Ola Landgren; Sergio A. Giralt; Saad Z. Usmani; Andriy Derkach; Malin Hultcrantz
Stem cell autograft minimal residual disease negativity and survival outcomes for multiple myeloma autotransplant

自体干细胞移植后微小残留病阴性及多发性骨髓瘤自体移植的生存结局

Blood Cancer Journal
IF11.6
2026-09-220
OAAI
Noriko Nishimura; Samantha Brown; Sarah Samorodnitsky; Sean M. Devlin; Mohammad Alhomoud; Parastoo Dahi; Charlotte Hughes; Eric Jergens; Heather J. Landau; Oscar B. Lahoud; Michael Scordo; Gunjan L. Shah; Ross Firestone; Hamza Hashmi; Hani Hassoun; Malin Hultcrantz; Neha Korde; Alexander M. Lesokhin; Kylee Maclachlan; Sham Mailankody; Francesco Maura; Maximilian Merz; Sridevi Rajeeve; Urvi A. Shah; Carlyn R. Tan; Gaurav K. Gupta; Elena Maryamchik; Evangelos Ntrivalas; Qi Gao; Mikhail Roshal; Saad Z. Usmani; Sergio A. Giralt; David J. Chung
Impact of granulocyte colony-stimulating factors on cytokine release syndrome during bispecific antibody initiation in relapsed/refractory multiple myeloma

粒细胞集落刺激因子对双特异性抗体启动期间细胞因子释放综合征的影响：在复发/难治性多发性骨髓瘤中的作用

Blood Cancer Journal
IF11.6
2026-08-070
OAAI
Alice X. Wang; Tala Shekarkhand; David Nemirovsky; Andriy Derkach; Carlyn R. Tan; Issam S. Hamadeh; Ross S. Firestone; Eric Jurgens; Kevin Miller; Dhwani Patel; Neha Korde; Alexander M. Lesokhin; Sham Mailankody; Hani Hassoun; Hamza Hashmi; Sridevi Rajeeve; Urvi A. Shah; Kylee Maclachlan; Gunjan L. Shah; Michael Scordo; Heather J. Landau; Sergio A. Giralt; Saad Z. Usmani; Malin Hultcrantz
Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma

在多发性骨髓瘤患者中，强效CD4+ CAR T细胞扩增与非ICANS神经毒性的发生相关（cilta-cel治疗）

Science Translational Medicine
IF14.6
2026-07-290
PRE
Eric M. Jurgens; Sneha Mitra; Kevin Herrera; David Nemirovsky; Brenden Bready; Andriy Derkach; Kinga Hosszu; Devin McAvoy; Ross S. Firestone; Sridevi Rajeeve; Alexander M. Lesokhin; Neha Korde; Carlyn R. Tan; Hamza Hashmi; Hani Hassoun; Kylee Maclachlan; Urvi A. Shah; Malin Hultcrantz; Maximilian Merz; Francesco Maura; Sergio A. Giralt; Gunjan L. Shah; Heather J. Landau; Michael Scordo; Ivan S. Kotchetkov; Bianca D. Santomasso; Jae Park; Christina S. Leslie; Saad Z. Usmani; Karlo Perica; Sham Mailankody
Whole-genome sequencing of cell-free DNA for assessment of minimal residual disease in high-risk smoldering multiple myeloma

无细胞DNA全基因组测序在评估高风险冒烟型多发性骨髓瘤微小残留病中的应用

HemaSphere
IF14.6
2026-04-160
OAAI
Chrissy Baker; Elizabeth Hill; Dickran Kazandjian; Marios Papadimitriou; Michael Durante; Abhishek Pandey; Bachisio Ziccheddu; Tomas Jelinek; David Coffey; Brian Walker; Ryan Young; Kylee Maclachlan; Neha Korde; Nickoli Parkinson; Zoe R. Goldstein; Alexi Runnels; William F. Hooper; Dan Landau; Nicolas Robine; Francesco Maura; Ola Landgren; Benjamin Diamond
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma

功能性高风险疾病与多发性骨髓瘤晚期CAR T细胞疗法后的不良预后相关

Blood Cancer Journal
IF11.6
2026-04-120
OAAI
Hamza Hashmi; Tara Sebastian; Sridevi Rajeeve; Tasmin Farzana; Ross S. Firestone; Eric M. Jurgens; Kevin C. Miller; Francesco Maura; Alexander M. Lesokhin; Carlyn R. Tan; Gunjan L. Shah; Neha Korde; Heather J. Landau; Maximillian Merz; Michael Scordo; Hani Hassoun; Kylee H. Maclachlan; Urvi A. Shah; Malin L. Hultcrantz; Andriy Derkach; David Nemirovsky; Sergio Giralt; Sham Mailankody; Saad Z. Usmani
IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM

IMS-IMWG 2025年共识基因组分期可预测达雷木单抗为基础的四联方案对NDMM的疗效。

Blood Advances
IF7.1
2026-02-190
OAAI
Kylee H. Maclachlan; Carlyn R. Tan; Tala Shekarkhand; Colin Rueda; Andriy Derkach; Hamza Hashmi; Hani Hassoun; Urvi A. Shah; Malin Hultcrantz; Alexander M. Lesokhin; Sham Mailankody; Francesco Maura; Maximillian Merz; Ross Firestone; Eric M. Jurgens; Kevin C. Miller; Sridevi Rajeeve; Sergio Giralt; Gunjan L. Shah; Michael Scordo
Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma

双特异性抗体治疗复发/难治性多发性骨髓瘤期间巨细胞病毒再激活

Blood Cancer Journal
IF11.6
2025-11-010
OAAI
Eric Jurgens; Tala Shekarkhand; Colin Rueda; David Nemirovsky; Andriy Derkach; Ross S. Firestone; Kevin Miller; Bruno Almeida Costa; Sridevi Rajeeve; Alexander M. Lesokhin; Neha Korde; Carlyn R. Tan; Hamza Hashmi; Hani Hassoun; Kylee Maclachlan; Urvi A. Shah; Malin Hultcrantz; Issam Hamadeh; Sergio A. Giralt; Gunjan L. Shah; Heather J. Landau; Michael Scordo; Saad Z. Usmani; Sham Mailankody; Zainab Shahid
Correction: Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma

更正：达鲁珠单抗耐药性对复发难治性多发性骨髓瘤接受CAR T细胞治疗后临床结局的影响

Blood Cancer Journal
IF11.6
2025-10-130
OA
Tara Sebastian; Sridevi Rajeeve; Tasmin Farzana; Ross Firestone; Eric Jurgens; Kevin Miller; Bruno Almeida Costa; Alexander Lesokhin; Carlyn Rose Tan; Gunjan Shah; Neha Korde; Heather Landau; Michael Scordo; Hani Hassoun; Kylee Maclachlan; Urvi Shah; Malin Hultcrantz; Andriy Derkach; Derkach Nemirovsky; Sergio Giralt; Saad Usmani; Sham Mailankody; Hamza Hashmi
Genomic landscape of IgM-MGUS and stable versus progressive asymptomatic Waldenström macroglobulinemia patients

IgM-MGUS及稳定期与进展期无症状华氏巨球蛋白血症患者的基因组景观

Blood
IF23.1
2025-09-290
PRE
Tina Bagratuni; Ourania Theologi; Christos Vlachos; Ioannis Kollias; Kylee Maclachlan; Foteini Aktypi; Nefeli Mavrianou-Koutsoukou; Christine Liacos; Konstantina Taouxi; Alexandra Papadimou; Katerina Chrisostomidou; Maria Sakkou; Irene Solia; Foteini Theodorakakou; Gianmarco Favrin; Maria Gavriatopoulou; Evangelos Terpos; Marzia Varettoni; Zachary H. Hunter; Steven Treon; Francesco Maura; Meletios A. Dimopoulos; Efstathios Kastritis
Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myeloma

升高的循环肿瘤细胞反映了多发性骨髓瘤中高增殖和基因组复杂性

HemaSphere
IF14.6
2025-09-230
PREAI
Juan-Jose Garces; Benjamin Diamond; Tereza Sevcikova; Serafim Nenarokov; Daniel Bilek; Eva Radova; Ondrej Venglar; Veronika Kapustova; Ross Firestone; Kylee Maclachlan; Anish Simhal; Lucie Broskevicova; Jan Vrana; Ludmila Muronova; Tereza Popkova; Jana Mihalyova; Hana Plonkova; Michael Durante; Bachisio Ziccheddu; Michal Simicek; Hearn Jay Cho; George Mulligan; Jonathan Keats; David Zihala; Ola Landgren; Roman Hajek; Saad Usmani; Francesco Maura; Tomas Jelinek
Temporal genomic dynamics shape clinical trajectory in multiple myeloma

时间基因组动力学塑造多发性骨髓瘤的临床轨迹

Nature Genetics
IF0
2025-08-200
OA
Francesco Maura; Marcella Kaddoura; Alexandra M. Poos; Linda B. Baughn; Bachisio Ziccheddu; Marc-Andrea Bärtsch; Anthony Cirrincione; Kylee Maclachlan; Monika Chojnacka; Benjamin Diamond; Marios Papadimitriou; Patrick Blaney; Lukas John; Philipp Reichert; Stefanie Huhn; Dylan Gagler; Yanming Zhang; Ahmet Dogan; Alexander M. Lesokhin; Faith Davies; Hartmut Goldschmidt; Roland Fenk; Katja C. Weisel; Elias K. Mai; Neha Korde; Gareth J. Morgan; S. Vincent Rajkumar; Shaji Kumar; Saad Usmani; Ola Landgren; Marc S. Raab; Niels Weinhold
Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma

daratumumab难治性对复发性难治性多发性骨髓瘤CAR T细胞治疗后临床结局的影响

Blood Cancer Journal
IF11.6
2025-08-140
OAAI
T. Sebastian; S. Rajeeve; T. Farzana; R. Firestone; E. Jurgens; K. Miller; B. Costa; A. Lesokhin; C. Tan; G. Shah; N. Korde; H. Landau; M. Scordo; H. Hassoun; K. Maclachlan; U. Shah; M. Hultcrantz; A. Derkach; D. Nemirovsky; S. Giralt; S. Z. Usmani; S. Mailankody; H. Hashmi
Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma

老年体弱患者接受BCMA靶向双特异性抗体治疗复发/难治性多发性骨髓瘤的结局

Blood Advances
IF7.1
2025-05-060
OA
Benjamin Adegbite; Carlyn Rose Tan; Tala Shekarkhand; Ross S. Firestone; Eric M. Jurgens; Kevin Miller; Alexander M. Lesokhin; Gunjan L. Shah; Neha Korde; Sridevi Rajeeve; Heather J. Landau; Michael Scordo; Hani Hassoun; Kylee H. Maclachlan; Urvi A. Shah; Malin Hultcrantz; Issam S. Hamadeh; Andriy Derkach; David Nemirovsky; Sergio A. Giralt; Sham Mailankody; Saad Z. Usmani; Hamza Hashmi
Restarting teclistamab and talquetamab after prolonged dose delay may not require re–step-up dosing

在长期剂量延迟后重新开始teclistamab和talquetamab治疗，可能不需要重新进行剂量递增。

Blood Advances
IF7.1
2025-03-100
OA
Carlyn Rose Tan; Alice Wang; David Nemirovsky; Andriy Derkach; Tala Shekarkhand; Issam Hamadeh; Kylee Maclachlan; Malin Hultcrantz; Hani Hassoun; Sham Mailankody; Alexander Lesokhin; Urvi A. Shah; Sridevi Rajeeve; Hamza Hashmi; Dhwani Patel; Ross Firestone; Eric Jurgens; Kevin Miller; Gunjan L. Shah; Michael Scordo; Saad Z. Usmani
Infectious Complications during Treatment with Commercial CAR T-Cell Therapy and Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma

商业化CAR T细胞疗法和双特异性抗体治疗复发/难治性多发性骨髓瘤期间的感染并发症

BLOOD
IF23.1
2024-11-050
PRE
Jurgens, Eric M.; Shekarkhand, Tala; Farzana, Tasmin; Rueda, Colin; Nemirovsky, David; Derkach, Andriy; Firestone, Ross S.; Nishimura, Noriko; Miller, Kevin; Costa, Bruno Almeida; Nath, Karthik; Rajeeve, Sridevi; Lesokhin, Alexander M.; Korde, Neha; Tan, Carlyn Rose; Hashmi, Hamza; Hassoun, Hani; Maclachlan, Kylee H.; Shah, Urvi A.; Hultcrantz, Malin; Hamadeh, Issam S.; Giralt, Sergio A.; Chung, David J.; Landau, Heather J.; Scordo, Michael; Shah, Gunjan L.; Usmani, Saad Z.; Mailankody, Sham; Shahid, Zainab
Manufacture of Anti-BCMA CAR T Cell Is Feasible after Salvage Autologous or Allogeneic Hematopoietic Stem Cell Transplantation

自体或异基因造血干细胞移植后，生产抗BCMA CAR T细胞是可行的。

BLOOD
IF23.1
2024-11-050
PRE
Shah, Gunjan L.; Perica, Karlo; Nagel, Katherine; Payson, Erica; Hosszu, Kinga K.; Chung, David J.; Landau, HeatherJ.; Scordo, Michael; Hultcrantz, Malin; Korde, Neha; Maclachlan, Kylee H.; Shah, Urvi A.; Tan, Carlyn Rose; Hashmi, Hamza; Lesokhin, Alexander M.; Rajeeve, Sridevi; Usmani, Saad Z.; Mailankody, Sham; Giralt, Sergio A.
Defining the Rates of Cytokine Release Syndrome Associated with Talquetamab Step-up Doses

定义与Talquetamab逐步增加剂量相关的细胞因子释放综合征的发生率

BLOOD
IF23.1
2024-11-050
PRE
Hamadeh, Issam S.; Shekarkhand, Tala; Rueda, Colin; Firestone, Ross S.; Wang, Alice X.; Korde, Neha; Hultcrantz, Malin; Lesokhin, Alexander M.; Mailankody, Sham; Hassoun, Hani; Shah, Urvi A.; Maclachlan, Kylee H.; Rajeeve, Sridevi; Hashmi, Hamza; Shah, Gunjan L.; Scordo, Michael; Chung, David J.; Landau, HeatherJ.; Giralt, Sergio A.; Usmani, Saad Z.; Tan, Carlyn Rose

研究方向

暂未获取到该数据
S
Saad Z. Usmani
H 指数:85论文数:1,145被引数:3.9万
A
Alexander M. Lesokhin
H 指数:56论文数:560被引数:2.4万
M
Malin Hultcrantz
H 指数:43论文数:439被引数:6,954
U
Urvi A. Shah
H 指数:32论文数:379被引数:4,154
N
Neha Korde
H 指数:40论文数:447被引数:5,875
S
Sham Mailankody
H 指数:47论文数:455被引数:8,504
G
Gunjan L. Shah
H 指数:43论文数:663被引数:8,077
C
Carlyn Tan
H 指数:26论文数:257被引数:3,169
H
Hani Hassoun
H 指数:47论文数:415被引数:9,010
S
Sergio Giralt
H 指数:122论文数:1,814被引数:6.2万